← All companies

EDIT

Editas Medicine, Inc.

EDIT Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$2.65

-0.04 -1.49%

Key statistics

from XBRL data in SEC filings

Market cap

$259M

Revenue (TTM)

$38.7M

Net income (TTM)

-$109M

EPS (TTM)

$-1.14

P/E ratio

—

Dividend yield

—

Free cash flow

-$166M

Cash

$124M

Total assets

$149M

Gross margin

—

52-week range

$1.66 – $4.54

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 18, 2026 8-K Entered a material agreement; Other events May 26, 2026 8-K Other events May 26, 2026 8-K Regulation FD disclosure; Other events May 26, 2026 8-K Regulation FD disclosure; Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Changed accountants Apr 7, 2026 8-K Regulation FD disclosure; Other events Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release) Mar 9, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure; Other events Oct 9, 2025 8-K Regulation FD disclosure; Other events Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Regulation FD disclosure; Other events Jun 12, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 2, 2025 8-K Regulation FD disclosure; Other events May 14, 2025 8-K Regulation FD disclosure; Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release) Mar 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Dec 17, 2024 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure; Other events Dec 12, 2024 8-K Amended charter or bylaws; Regulation FD disclosure Dec 10, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Nov 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 22, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Oct 4, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change Jun 27, 2024 8-K Regulation FD disclosure; Other events Jun 14, 2024 8-K Shareholder vote results May 31, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024